354 related articles for article (PubMed ID: 33213722)
21. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.
Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD
JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684
[TBL] [Abstract][Full Text] [Related]
22. Head-to-head comparison of prasugrel versus ticagrelor in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Sakurai R; Burazor I; Bonneau HN; Kaneda H
J Interv Cardiol; 2017 Oct; 30(5):457-464. PubMed ID: 28804959
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy and safety of oral P2Y
Farmakis IT; Zafeiropoulos S; Doundoulakis I; Pagiantza A; Karagiannidis E; Moysidis DV; Stalikas N; Kassimis G; Michalis LK; Karvounis H; Giannakoulas G
Open Heart; 2022 Apr; 9(1):. PubMed ID: 35428703
[TBL] [Abstract][Full Text] [Related]
24. Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
Welsh RC; Sidhu RS; Cairns JA; Lavi S; Kedev S; Moreno R; Cantor WJ; Stankovic G; Meeks B; Yuan F; Džavík V; Jolly SS
Can J Cardiol; 2019 Oct; 35(10):1377-1385. PubMed ID: 31492492
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction - Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health.
Kim MC; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn Y; Ahn TH; Seung KB; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK; Chae JK;
Circ J; 2018 Jun; 82(7):1866-1873. PubMed ID: 29643279
[TBL] [Abstract][Full Text] [Related]
26. Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome.
Omerovic E; Erlinge D; Koul S; Frobert O; Andersson J; Ponten J; Björklund F; Kastberg R; Petzold M; Ljungman C; Bolin K; Redfors B
Am Heart J; 2022 Sep; 251():70-77. PubMed ID: 35644221
[TBL] [Abstract][Full Text] [Related]
27. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.
Raposeiras-Roubín S; Abu-Assi E; D'Ascenzo F; Fernández-Barbeira S; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Quadri G; Rognoni A; Boccuzzi G; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Flores Blanco P; Garay A; Varbella F; Tommassini F; Caneiro Queija B; Cobas Paz R; Cespón Fernández M; Muñoz Pousa I; Gallo D; Morbiducci U; Domínguez-Rodríguez A; Baz-Alonso JA; Valdés M; Cequier Á; Gaita F; Alexopoulos D; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):298-304. PubMed ID: 29954720
[TBL] [Abstract][Full Text] [Related]
28. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
29. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
Wang Z; Zhou DY; Su Y; Si LY; Xu Q
BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
[TBL] [Abstract][Full Text] [Related]
30. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.
Hemetsberger R; Richardt G; Lahu S; Valina C; Menichelli M; Abdelghani M; Wöhrle J; Toelg R; Witzenbichler B; Mankerious N; Liebetrau C; Bernlochner I; Hamm CW; Allali A; Joner M; Fusaro M; Xhepa E; Hapfelmeier A; Kufner S; Sager HB; Schüpke S; Laugwitz KL; Schunkert H; Neumann FJ; Kastrati A; Cassese S
Cardiovasc Revasc Med; 2022 Aug; 41():122-128. PubMed ID: 35045943
[TBL] [Abstract][Full Text] [Related]
31. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial.
Behnes M; Lahu S; Ndrepepa G; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Gewalt S; Witzenbichler B; Hochholzer W; Sibbing D; Cassese S; Angiolillo DJ; Hemetsberger R; Valina C; Müller A; Kufner S; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Joner M; Fusaro M; Richardt G; Laugwitz KL; Neumann FJ; Schunkert H; Schüpke S; Kastrati A; Akin I
Clin Res Cardiol; 2023 Apr; 112(4):518-528. PubMed ID: 35789430
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
De Servi S; Goedicke J; Schirmer A; Widimsky P
Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
[TBL] [Abstract][Full Text] [Related]
33. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.
Faridi KF; Garratt KN; Kennedy KF; Maddox TM; Secemsky EA; Butala NM; Yeh RW
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006275. PubMed ID: 32156164
[TBL] [Abstract][Full Text] [Related]
34. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View.
Angoulvant D; Sabouret P; Savage MP
Am J Cardiovasc Drugs; 2021 Sep; 21(5):483-486. PubMed ID: 33674980
[TBL] [Abstract][Full Text] [Related]
35. Real-World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome.
Yildirim M; Mueller-Hennessen M; Milles BR; Biener M; Hund H; Frey N; Giannitsis E; Salbach C
J Am Heart Assoc; 2023 Aug; 12(16):e030879. PubMed ID: 37581388
[TBL] [Abstract][Full Text] [Related]
36. Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial.
Tarantini G; Mojoli M; Varbella F; Caporale R; Rigattieri S; Andò G; Cirillo P; Pierini S; Santarelli A; Sganzerla P; De Cesare N; Limbruno U; Lupi A; Ricci R; Cernetti C; Favero L; Saia F; Roncon L; Gasparetto V; Ferlini M; Ronco F; Ferri L; Trabattoni D; Russo A; Guiducci V; Penzo C; Tarantino F; Mauro C; Marchese A; Castiglioni B; La Manna A; Martinato M; Gregori D; Angiolillo DJ; Musumeci G
Trials; 2020 Nov; 21(1):966. PubMed ID: 33234137
[TBL] [Abstract][Full Text] [Related]
37. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Yudi MB; Clark DJ; Farouque O; Eccleston D; Andrianopoulos N; Duffy SJ; Brennan A; Lefkovits J; Ramchand J; Yip T; Oqueli E; Reid CM; Ajani AE;
Intern Med J; 2016 May; 46(5):559-65. PubMed ID: 26909472
[TBL] [Abstract][Full Text] [Related]
38. Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
Bonello L; Laine M; Camoin-Jau L; Noirot F; Guieu R; Dignat-George F; Paganelli F; Frere C
Thromb Haemost; 2015 Oct; 114(4):702-7. PubMed ID: 26311415
[TBL] [Abstract][Full Text] [Related]
39. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk.
Lahu S; Presch A; Ndrepepa G; Menichelli M; Valina C; Hemetsberger R; Witzenbichler B; Bernlochner I; Joner M; Xhepa E; Hapfelmeier A; Kufner S; Rifatov N; Sager HB; Mayer K; Kessler T; Laugwitz KL; Richardt G; Schunkert H; Neumann FJ; Sibbing D; Angiolillo DJ; Kastrati A; Cassese S
Circ Cardiovasc Interv; 2022 Oct; 15(10):e012204. PubMed ID: 36256695
[TBL] [Abstract][Full Text] [Related]
40. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
Aytekin A; Scalamogna M; Coughlan JJ; Lahu S; Ndrepepa G; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Witzenbichler B; Hochholzer W; Sibbing D; Angiolillo DJ; Hemetsberger R; Tölg R; Valina C; Müller A; Kufner S; Liebetrau C; Xhepa E; Hapfelmeier A; Sager HB; Joner M; Richardt G; Laugwitz KL; Neumann FJ; Schunkert H; Schüpke S; Kastrati A; Cassese S
Clin Res Cardiol; 2024 Jul; 113(7):1060-1069. PubMed ID: 38740722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
